{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:50:45Z","timestamp":1740142245074,"version":"3.37.3"},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"37","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation, China","doi-asserted-by":"publisher","award":["81974528","82174035","81773959"],"award-info":[{"award-number":["81974528","82174035","81773959"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation, China","doi-asserted-by":"publisher","award":["2021CFA015"],"award-info":[{"award-number":["2021CFA015"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018570","name":"Central Funds Guiding the Local Science and Technology Development","doi-asserted-by":"publisher","award":["2020ZYYD016"],"award-info":[{"award-number":["2020ZYYD016"]}],"id":[{"id":"10.13039\/501100018570","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Foundation for Tumor Microenvironment and Immunotherapy Key Laboratory of Hubei province, China","award":["2019KZL11"],"award-info":[{"award-number":["2019KZL11"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>NR2F1-AS1 is a long non-coding RNA (lnc RNA) that is involved\nin different biological processes. It plays an integral role in the pathophysiology\nof human diseases, especially tumorigenesis and progression. Therefore, it may be a\npromising target for numerous tumor biotherapeutics. The current review study aimed to\nshow the pathophysiological activities and processes of RNA NR2F1-AS1 in cancer\ncells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The contents of the present review were based on information obtained from\nPubMed. In the data search, \u201cNR2F1-AS1\u201d was chosen as the first keyword, whereas\n\u201ccancer\u201d was chosen as the second keyword. This review selected and summarized\nstudies published between 2019-2021, concerning the biological functions and mechanisms\nof NR2F1-AS1 in the development of tumorigenesis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>It was found that NR2F1-AS1 regulates a variety of biological activities such as\nproliferation, invasion, migration, and apoptosis. It acts as an oncogene because it is abnormally\nexpressed and promotes the progression of cancer in a variety of malignancies,\nincluding esophageal squamous cell carcinoma, non-small cell lung cancer, breast cancer,\nneuroblastoma, endometrial cancer, thyroid cancer, and gastric cancer. However, it\nwas evident that NR2F1-AS1 inhibits the progression of cancer in cervical squamous cell\ncarcinoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>NR2F1-AS1 is a potential new biomarker and therapeutic target for the treatment\nof different cancers.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666230112165503","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T09:02:02Z","timestamp":1673859722000},"page":"4266-4276","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis"],"prefix":"10.2174","volume":"30","author":[{"given":"Jiahui","family":"Hu","sequence":"first","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Peng","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"},{"name":"Hubei Key Laboratory of Tumor\nMicroenvironment and Immunotherapy, China Three Gorges University, Yichang 443002, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjie","family":"Yang","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuyue","family":"Shen","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfu","family":"Yuan","sequence":"additional","affiliation":[{"name":"Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional\nChinese Medicine, China Three Gorges University, Yichang 443002, China"},{"name":"College of Basic Medical\nScience, China Three Gorges University, Yichang 443002, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/embo-reports\/kve230","volume":"2","author":"Mattick J.S.","year":"2001","unstructured":"Mattick J.S.; Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2001,2(11),986-991","journal-title":"EMBO Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","volume":"339","author":"Shi X.","year":"2013","unstructured":"Shi X.; Sun M.; Liu H.; Yao Y.; Song Y.; Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Lett 2013,339(2),159-166","journal-title":"Cancer Lett"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","volume":"220","author":"Bridges M.C.","year":"2021","unstructured":"Bridges M.C.; Daulagala A.C.; Kourtidis A.; LNCcation: lncRNA localization and function. J Cell Biol 2021,220(2),e202009045","journal-title":"J Cell Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jmcb\/mju013","volume":"6","author":"Zhang A.","year":"2014","unstructured":"Zhang A.; Xu M.; Mo Y.Y.; Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol 2014,6(3),181-191","journal-title":"J Mol Cell Biol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e01776","DOI":"10.7554\/eLife.01776","volume":"3","author":"Krawczyk M.","year":"2014","unstructured":"Krawczyk M.; Emerson B.M.; p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-\u03baB complexes. eLife 2014,3,e01776","journal-title":"eLife"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ccell.2015.02.004","volume":"27","author":"Liu B.","year":"2015","unstructured":"Liu B.; Sun L.; Liu Q.; Gong C.; Yao Y.; Lv X.; Lin L.; Yao H.; Su F.; Li D.; Zeng M.; Song E.; A cytoplasmic NF-\u03baB interacting long noncoding RNA blocks I\u03baB phosphorylation and suppresses breast cancer metastasis. Cancer Cell 2015,27(3),370-381","journal-title":"Cancer Cell"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e00762","DOI":"10.7554\/eLife.00762","volume":"2","author":"Rapicavoli N.A.","year":"2013","unstructured":"Rapicavoli N.A.; Qu K.; Zhang J.; Mikhail M.; Laberge R.M.; Chang H.Y.; A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife 2013,2,e00762","journal-title":"eLife"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"Peng W-X.","year":"2017","unstructured":"Peng W-X.; Koirala P.; Mo Y-Y.; LncRNA-mediated regulation of cell signaling in cancer. Oncogene 2017,36(41),5661-5667","journal-title":"Oncogene"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e20210836","DOI":"10.1084\/jem.20210836","volume":"219","author":"Khalil B.D.","year":"2022","unstructured":"Khalil B.D.; Sanchez R.; Rahman T.; Rodriguez-Tirado C.; Moritsch S.; Martinez A.R.; Miles B.; Farias E.; Mezei M.; Nobre A.R.; Singh D.; Kale N.; Sproll K.C.; Sosa M.S.; Aguirre-Ghiso J.A.; An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. J Exp Med 2022,219(1),e20210836","journal-title":"J Exp Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"767965","DOI":"10.3389\/fnmol.2021.767965","volume":"14","author":"Tocco C.","year":"2021","unstructured":"Tocco C.; Bertacchi M.; Studer M.; Structural and functional aspects of the neurodevelopmental gene NR2F1: From animal models to human pathology. Front Mol Neurosci 2021,14,767965","journal-title":"Front Mol Neurosci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e104163","DOI":"10.15252\/embj.2019104163","volume":"39","author":"Bertacchi M.","year":"2020","unstructured":"Bertacchi M.; Romano A.L.; Loubat A.; Tran Mau-Them F.; Willems M.; Faivre L.; Khau van Kien P.; Perrin L.; Devillard F.; Sorlin A.; Kuentz P.; Philippe C.; Garde A.; Neri F.; Di Giaimo R.; Oliviero S.; Cappello S.; D\u2019Incerti L.; Frassoni C.; Studer M.; NR2F1 regulates regional progenitor dynamics in the mouse neocortex and cortical gyrification in BBSOAS patients. EMBO J 2020,39(13),e104163","journal-title":"EMBO J"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1038\/ncomms7170","volume":"6","author":"Sosa M.S.","year":"2015","unstructured":"Sosa M.S.; Parikh F.; Maia A.G.; Estrada Y.; Bosch A.; Bragado P.; Ekpin E.; George A.; Zheng Y.; Lam H.M.; Morrissey C.; Chung C.Y.; Farias E.F.; Bernstein E.; Aguirre-Ghiso J.A.; NR2F1 controls tumour cell dormancy via SOX9- and RAR\u03b2-driven quiescence programmes. Nat Commun 2015,6(1),6170","journal-title":"Nat Commun"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nmeth.3235","volume":"12","author":"Rusk N.","year":"2015","unstructured":"Rusk N.; Understanding noncoding RNAs. Nat Methods 2015,12(1),35-35","journal-title":"Nat Methods"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/jcmm.13605","volume":"22","author":"Huang H.","year":"2018","unstructured":"Huang H.; Chen J.; Ding C.M.; Jin X.; Jia Z.M.; Peng J.; Lnc  2F1-  1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting  1 via miR-363. J Cell Mol Med 2018,22(6),3238-3245","journal-title":"J Cell Mol Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.26355\/eurrev_202004_20831","volume":"24","author":"Ren P.","year":"2020","unstructured":"Ren P.; Zhang H.; Chang L.; Hong X.D.; Xing L.; LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT. Eur Rev Med Pharmacol Sci 2020,24(7),3686-3693","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbrc.2019.09.015","volume":"519","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Zheng A.; Xu R.; Zhou F.; Hao A.; Yang H.; Yang P.; NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway. Biochem Biophys Res Commun 2019,519(3),497-504","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1111\/jcmm.14386","volume":"23","author":"Guo F.","year":"2019","unstructured":"Guo F.; Fu Q.; Wang Y.; Sui G.; Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p\/ CCND1 axis. J Cell Mol Med 2019,23(9),5907-5919","journal-title":"J Cell Mol Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/jcb.29435","volume":"121","author":"Yang C.","year":"2020","unstructured":"Yang C.; Liu Z.; Chang X.; Xu W.; Gong J.; Chai F.; Cui D.; NR2F1-AS1 regulated miR-423-5p\/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma. J Cell Biochem 2020,121(2),2009-2018","journal-title":"J Cell Biochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.18632\/aging.103564","volume":"13","author":"Zhang C.","year":"2021","unstructured":"Zhang C.; Wu S.; Song R.; Liu C.; Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression. Aging 2021,13(5),7660-7675","journal-title":"Aging"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1111\/jcmm.15499","volume":"24","author":"Zhang Q.","year":"2020","unstructured":"Zhang Q.; Li T.; Wang Z.; Kuang X.; Shao N.; Lin Y.; lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1\/IGF-1R\/ERK pathway. J Cell Mol Med 2020,24(14),8236-8247","journal-title":"J Cell Mol Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.26355\/eurrev_202012_24174","volume":"24","author":"Liu L.","year":"2020","unstructured":"Liu L.; Zhao H.; He H.H.; Huang J.; Xu Y.Y.; Li X.L.; Wu Y.; Wang J.; Zhu Y.B.; Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p\/TRIM2 axis. Eur Rev Med Pharmacol Sci 2020,24(24),12748-12756","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1691\/ph.2019.8905","volume":"74","author":"Wang L.","year":"2019","unstructured":"Wang L.; Zhao S.; Mingxin Y.U.; LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4. Pharmazie 2019,74(5),295-300","journal-title":"Pharmazie"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s43032-020-00149-y","volume":"27","author":"Peng J.","year":"2020","unstructured":"Peng J.; Hou F.; Zhu W.; Li J.; Teng Z.; lncRNA NR2F1-AS1 regulates miR-17\/SIK1 axis to suppress the invasion and migration of cervical squamous cell carcinoma cells. Reprod Sci 2020,27(7),1534-1539","journal-title":"Reprod Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"12345","DOI":"10.1080\/21655979.2021.2001168","volume":"12","author":"Zuo F.","year":"2021","unstructured":"Zuo F.; Zhang Y.; Li J.; Yang S.; Chen X.; Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression. Bioengineered 2021,12(2),12345-12356","journal-title":"Bioengineered"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3881932","DOI":"10.1155\/2021\/3881932","volume":"2021","author":"Liao X.","year":"2021","unstructured":"Liao X.; Wen L.; Luo L.; The effect and mechanism of lncRNA NR2F1-As1\/miR-493-5p\/MAP3K2 axis in the progression of gastric cancer. J Oncol 2021,2021,3881932","journal-title":"J Oncol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"688949","DOI":"10.3389\/fcell.2021.688949","volume":"9","author":"Lv J.","year":"2021","unstructured":"Lv J.; Zhang S.; Liu Y.; Li C.; Guo T.; Zhang S.; Li Z.; Jiao Z.; Sun H.; Zhang Y.; Xu L.; NR2F1-AS1\/miR-190a\/PHLDB2 induces the epithelial\u2013mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3. Front Cell Dev Biol 2021,9,688949","journal-title":"Front Cell Dev Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"Ferlay J.","year":"2015","unstructured":"Ferlay J.; Soerjomataram I.; Dikshit R.; Eser S.; Mathers C.; Rebelo M.; Parkin D.M.; Forman D.; Bray F.; Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015,136(5),E359-E386","journal-title":"Int J Cancer"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000486422","volume":"85","author":"Chmielik E.","year":"2018","unstructured":"Chmielik E.; Rusinek D.; Oczko-Wojciechowska M.; Jarzab M.; Krajewska J.; Czarniecka A.; Jarzab B.; Heterogeneity of thyroid cancer. Pathobiology 2018,85(1-2),117-129","journal-title":"Pathobiology"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3892\/mmr.2017.6842","volume":"16","author":"Cheng L.","year":"2017","unstructured":"Cheng L.; Zhou R.; Chen M.; Feng L.; Li H.; MicroRNA-150 targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in papillary thyroid carcinoma. Mol Med Rep 2017,16(2),2217-2224","journal-title":"Mol Med Rep"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev-med-061512-105739","volume":"65","author":"Carling T.","year":"2014","unstructured":"Carling T.; Udelsman R.; Thyroid cancer. Annu Rev Med 2014,65(1),125-137","journal-title":"Annu Rev Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amjsurg.2017.09.008","volume":"216","author":"Vasileiadis I.","year":"2018","unstructured":"Vasileiadis I.; Boutzios G.; Karalaki M.; Misiakos E.; Karatzas T.; Papillary thyroid carcinoma of the isthmus: Total thyroidectomy or isthmusectomy? Am J Surg 2018,216(1),135-139","journal-title":"Am J Surg"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2537","volume":"17","author":"Weis S.M.","year":"2011","unstructured":"Weis S.M.; Cheresh D.A.; Tumor angiogenesis: Molecular pathways and therapeutic targets. Nat Med 2011,17(11),1359-1370","journal-title":"Nat Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s10147-003-0342-8","volume":"8","author":"Sato Y.","year":"2003","unstructured":"Sato Y.; Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy. Int J Clin Oncol 2003,8(4),200-206","journal-title":"Int J Clin Oncol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jjco\/hyx176","volume":"48","author":"Nakagawara A.","year":"2018","unstructured":"Nakagawara A.; Li Y.; Izumi H.; Muramori K.; Inada H.; Nishi M.; Neuroblastoma. Jpn J Clin Oncol 2018,48(3),214-241","journal-title":"Jpn J Clin Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3892\/ol.2015.3088","volume":"9","author":"Ke X.X.","year":"2015","unstructured":"Ke X.X.; Zhang D.; Zhao H.; Hu R.; Dong Z.; Yang R.; Zhu S.; Xia Q.; Ding H.F.; Cui H.; Phox2B correlates with MYCN and is a prognostic marker for neuroblastoma development. Oncol Lett 2015,9(6),2507-2514","journal-title":"Oncol Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2012.76","volume":"32","author":"Yeramian A.","year":"2013","unstructured":"Yeramian A.; Moreno-Bueno G.; Dolcet X.; Catasus L.; Abal M.; Colas E.; Reventos J.; Palacios J.; Prat J.; Matias-Guiu X.; Endometrial carcinoma: Molecular alterations involved in tumor development and progression. Oncogene 2013,32(4),403-413","journal-title":"Oncogene"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"Cohen P.A.","year":"2019","unstructured":"Cohen P.A.; Jhingran A.; Oaknin A.; Denny L.; Cervical cancer. Lancet 2019,393(10167),169-182","journal-title":"Lancet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12029-020-00572-z","volume":"53","author":"Imounga L.M.","year":"2022","unstructured":"Imounga L.M.; Plenet J.; Belliardo S.; Chine E.C.; Louvel D.; Cenciu B.; Couppi\u00e9 P.; Alsibai K.D.; Nacher M.; Gastric cancer incidence and mortality in french guiana: South American or french? J Gastrointest Cancer 2022,53(1),204-210","journal-title":"J Gastrointest Cancer"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230112165503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212668\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666230112165503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T20:04:17Z","timestamp":1693685057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212668\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666230112165503","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}